Sanara MedTech
SMTI
$32.35
Share price
0.43%
Change (1 day)
-23.70%
Change (1 year)
Categories
P/S ratio for Sanara MedTech (SMTI)
P/S ratio as of April 2024 (TTM): 4.28
According to Sanara MedTech's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.28023. At the end of 2023 the company had a P/S ratio of 5.40.
P/S ratio history for Sanara MedTech from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 5.40 | -34.48% |
| 2022 | 8.24 | -11.77% |
| 2021 | 9.34 | -53.64% |
| 2020 | 20.1 | 312.39% |
| 2019 | 4.89 | 269.18% |
| 2018 | 1.32 | 23.92% |
| 2017 | 1.07 | 41.5% |
| 2016 | 0.7548 | -73.19% |
| 2015 | 2.82 | 27.8% |
| 2014 | 2.20 | -57.72% |
| 2013 | 5.21 | 122.24% |
| 2012 | 2.34 | -77.4% |
| 2011 | 10.4 | -42.81% |
| 2010 | 18.1 | -92.78% |
| 2009 | 251 | -26.06% |
| 2008 | 340 | |
| 2004 | N/A | |
| 2001 | > 1000 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 1.02 | -76.24% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 92.5 | 2,061.07% | 🇺🇸 USA |